- Conditions: Fabry Disease; Neuropathic Pain
Interventions: Drug: Gabapentin; Drug: placebo
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute; Genzyme
Recruiting - verified April 2012 - Condition: Healthy
Interventions: Drug: Memantine; Drug: Placebo
Sponsors: Yale University; Yale University
Recruiting - verified May 2012 - Conditions: Depressive Disorder; Depressive Disorder, Major; Depression
Intervention: Other: Citalopram
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified March 2012 - Condition: Schizophrenia
Interventions: Drug: Memantine; Drug: Placebo
Sponsors: University of California, San Diego; University of California, San Diego
Recruiting - verified March 2012 - Conditions: MDD; Citalopram; Major Depressive Disorder
Intervention: Drug: citalopram
Sponsors: Mclean Hospital; Mclean Hospital
Recruiting - verified April 2012 - Condition: Degenerative Joint Disease of Hip and Knee.
Interventions: Drug: Placebo; Drug: Gapabentin
Sponsors: University of Medicine and Dentistry New Jersey; University of Medicine and Dentistry New Jersey
Recruiting - verified March 2012 - Condition: Hot Flashes in Men With Prostate Cancer Receiving Androgen Ablation Therapy
Interventions: Drug: Gabapentin; Drug: Venlafaxine
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison
Recruiting - verified February 2012 - Conditions: Attention Deficit Hyperactivity Disorder (ADHD); Executive Function Deficits (EFD)
Interventions: Drug: Placebo; Drug: Memantine Hydrochloride; Drug: OROS-Methylphenidate
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; American Professional Society of ADHD and Related Disorders
Not yet recruiting - verified April 2012 - Condition: Parkinson's Disease
Intervention: Drug: Carbidopa-Levodopa
Sponsors: Northwestern University; Northwestern University
Recruiting - verified February 2012 - Condition: Spinal Cord Injury
Interventions: Drug: escitalopram oxalate; Drug: Cyproheptadine; Drug: sugar pill; Other: Graded intensity exercise
Sponsors: Rehabilitation Institute of Chicago; T. George Hornby; University of Medicine and Dentistry New Jersey; Rehabilitation Institute of Chicago
Recruiting - verified February 2012 - Condition: Alcohol Drinking
Interventions: Drug: Naltrexone and memantine; Drug: Naltrexone and Placebo
Sponsors: Yale University; Yale University; National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - verified January 2012 - Conditions: Parkinson's Disease; Motor Fluctuations
Interventions: Drug: DM-1992; Drug: Sinemet IR
Sponsors: Depomed; Depomed
Recruiting - verified April 2012 - Conditions: Acute Lymphoblastic Leukemia; Neuropathy; Neuropathic Pain
Interventions: Drug: gabapentin; Drug: placebo
Sponsors: St. Jude Children's Research Hospital; St. Jude Children's Research Hospital
Recruiting - verified January 2012 - Conditions: Sciatica; Radiculopathy
Interventions: Procedure: epidural steroid injection; Procedure: Sham epidural steroid injection; Drug: Gabapentin; Drug: Placebo gabapentin
Sponsors: Johns Hopkins University; Johns Hopkins University; Walter Reed National Military Medical Center; Brooke Army Medical Center; Landstuhl Regional Medical Center; DC VA Hospital; San Diego Naval Hospital; Case Western Reserve University; Penn State-Hershey
Recruiting - verified March 2012 - Condition: Cocaine Use Disorders
Interventions: Drug: High-dose donepezil; Drug: Low-dose donepezil; Drug: Selegiline; Drug: Placebo
Sponsors: Midwest Biomedical Research Foundation; Midwest Biomedical Research Foundation; National Institute on Drug Abuse (NIDA)
Recruiting - verified May 2012 - Conditions: Dyskinesias; Parkinson Disease; Movement Disorders; Parkinsonian Disorders; Anti-Dyskinesia Agents
Interventions: Drug: AFQ056; Drug: Placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Conditions: Dyskinesias; Parkinson Disease; Movement Disorders; Parkinsonian Disorders; Anti-Dyskinesia Agents
Intervention: Drug: AFQ056
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Condition: Parkinson Disease
Interventions: Drug: ropinirole monotherapy; Drug: placebo monotherapy
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified March 2012 - Condition: Major Depressive Disorder
Interventions: Drug: Placebo; Drug: Vilazodone; Drug: Vilazodone; Drug: Citalopram
Sponsors: Forest Laboratories; Forest Laboratories
Recruiting - verified March 2012 - Condition: Cocaine Dependence
Interventions: Drug: levodopa carbidopa and entacapone (LCE); Drug: Placebo
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute
Not yet recruiting - verified December 2011 - Conditions: Renal Disease; End Stage Renal Disease
Intervention: Drug: Droxidopa
Sponsors: Chelsea Therapeutics; Chelsea Therapeutics
Not yet recruiting - verified March 2012 - Condition: Cocaine Dependence
Interventions: Drug: Citalopram; Drug: Citalopram; Drug: Placebo
Sponsors: The University of Texas Health Science Center, Houston; Joy Schmitz; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2012 - Conditions: Dyskinesia,; Drug-induced
Interventions: Drug: AQW051; Drug: AQW051; Drug: Placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified November 2011 - Condition: Bipolar Depression
Interventions: Drug: ESC + CBX; Drug: ESC + PBO.; Drug: ESC+CBX
Sponsors: Loyola University; Loyola University; Stanley Medical Research Institute
Recruiting - verified December 2011 - Conditions: Tourniquet-induced Pain; Tourniquet-induced Hypertension
Interventions: Drug: gabapentin 600 mg po; Drug: Placebo pill given one hour before surgery
Sponsors: Baylor College of Medicine; Baylor College of Medicine
Not yet recruiting - verified September 2011 - Condition: Brain Cancer
Interventions: Drug: Temozolomide; Drug: Memantine; Drug: Mefloquine; Drug: Metformin
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified January 2012 - Condition: Major Depressive Disorder
Intervention: Drug: Escitalopram
Sponsors: Wyss Institute at Harvard University; Wyss Institute at Harvard University; Massachusetts General Hospital; Martinos Center for Biomedical Imaging; Massachusetts Institute of Technology
Recruiting - verified April 2012 - Condition: Insomnia
Intervention: Drug: Gabapentin
Sponsors: University at Buffalo; University at Buffalo
Recruiting - verified August 2011 - Condition: Parkinson's Disease
Intervention: Drug: IPX066
Sponsors: IMPAX Laboratories, Inc.; IMPAX Laboratories, Inc.; Michael J. Fox Foundation for Parkinson's Research
Recruiting - verified August 2011 - Conditions: Nonfluent Aphasia; Stroke
Intervention: Drug: levodopa/carbidopa
Sponsors: Rehabilitation Institute of Chicago; Rehabilitation Institute of Chicago; U.S. Department of Education
Recruiting - verified September 2011 - Conditions: Dyskinesia; Levodopa Induced Dyskinesia; Parkinson's Disease
Intervention: Drug: ADS-5102 (extended release amantadine HCl)
Sponsors: Adamas Pharmaceuticals, Inc.; Adamas Pharmaceuticals, Inc.
Recruiting - verified May 2012 - Condition: Body Dysmorphic Disorder
Intervention: Procedure: PET scan and MRI scan
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified January 2012 - Condition: Cocaine Dependence
Interventions: Drug: levodopa/carbidopa; Drug: Ropinirole; Drug: Placebo
Sponsors: The University of Texas Health Science Center, Houston; The University of Texas Health Science Center, Houston
Recruiting - verified February 2012 - Condition: Alzheimer's Disease
Intervention: Drug: R-pramipexole
Sponsors: Virginia Commonwealth University; Virginia Commonwealth University; University of Kansas; Alzheimer’s Drug Discovery Foundation
Recruiting - verified January 2012 - Conditions: Dyskinesias; Parkinson Disease; Movement Disorders; Parkinsonian Disorders
Interventions: Drug: AFQ056; Drug: Placebo
Sponsors: Novartis; Novartis
Recruiting - verified April 2012 - Conditions: Orthostatic Hypotension; Multiple System Atrophy
Interventions: Drug: Droxidopa; Drug: Pyridostigmine Bromide
Sponsors: Mayo Clinic; Mayo Clinic
Recruiting - verified December 2011 - Condition: Depression
Interventions: Drug: Duloxetine; Drug: Escitalopram; Drug: BMS-820836 Placebo; Drug: BMS-820836; Drug: BMS-820836; Drug: BMS-820836; Drug: BMS-820836
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified August 2011 - Conditions: TBI; Major Depression; Other Psychiatric Disorders
Intervention: Drug: Escitalopram
Sponsors: Johns Hopkins University; Johns Hopkins University; Forest Laboratories
Recruiting - verified February 2009 - Condition: Autism Spectrum Disorder
Intervention: Drug: Memantine
Sponsors: Holland Bloorview Kids Rehabilitation Hospital; Holland Bloorview Kids Rehabilitation Hospital; Autism Speaks
Recruiting - verified February 2012 - Condition: Treatment Outcome
Interventions: Drug: Lu AA21004; Drug: Escitalopram
Sponsors: Takeda Global Research & Development Center, Inc.; Takeda Global Research & Development Center, Inc.
Recruiting - verified May 2012 - Condition: Major Depressive Disorder
Interventions: Drug: PNB01 fixed dose combination of pipamperone and citalopram; Drug: Citalopram; Drug: Pipamperone
Sponsors: PharmaNeuroBoost N.V.; PharmaNeuroBoost N.V.
Recruiting - verified March 2012 - Condition: Parkinson's Disease
Intervention: Drug: SYN115
Sponsors: Biotie Therapies Inc.; Biotie Therapies Inc.
Recruiting - verified January 2012 - Condition: Angelman Syndrome
Intervention: Drug: Levodopa/carbidopa
Sponsors: Children's Hospital Boston; Wen-Hann Tan; Rady Children's Hospital, San Diego; University of California, San Francisco; Baylor College of Medicine; Vanderbilt University; Greenwood Genetic Center; Angelman Syndrome Foundation; FDA Office of Orphan Products Development
Recruiting - verified March 2012 - Condition: Autism Spectrum Disorders
Intervention: Drug: Memantine
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified February 2012 - Condition: Cocaine Abuse
Intervention: Drug: L-dopa / carbidopa / entacapone (LCE)
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute; National Institute on Drug Abuse (NIDA); Columbia University
Recruiting - verified December 2011 - Condition: Influenza
Interventions: Drug: Amantadine, Ribavirin, Oseltamivir; Drug: Oseltamivir
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2012 - Conditions: Depression; Asthma
Interventions: Drug: Escitalopram; Drug: Placebo
Sponsors: University of Texas Southwestern Medical Center; University of Texas Southwestern Medical Center; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2012 - Condition: Gait Disorders, Neurologic
Intervention: Drug: droxidopa
Sponsors: Chelsea Therapeutics; Chelsea Therapeutics
Not yet recruiting - verified March 2012 - Condition: Major Depressive Disorder
Intervention: Drug: Escitalopram
Sponsors: Forest Laboratories; Forest Laboratories
Recruiting - verified February 2012 - Condition: Amblyopia
Interventions: Drug: Levodopa/Carbidopa; Drug: Placebo; Other: Patching
Sponsors: Jaeb Center for Health Research; Jaeb Center for Health Research; National Eye Institute (NEI)
Recruiting - verified January 2012 - Conditions: Orthostatic Hypotension; Parkinson's Disease
Intervention: Drug: Droxidopa
Sponsors: Chelsea Therapeutics; Chelsea Therapeutics
Recruiting - verified March 2012 - Conditions: Complicated Grief; Bereavement
Interventions: Drug: Citalopram; Behavioral: Complicated Grief Treatment; Other: Placebo
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute; National Institute of Mental Health (NIMH); American Foundation for Suicide Prevention
Recruiting - verified March 2012 - Condition: Impulsive Behavior
Interventions: Drug: Tolcapone; Other: Placebo
Sponsors: University of California, San Francisco; University of California, San Francisco; University of California, Berkeley; Department of Defense
Recruiting - verified March 2012 - Condition: Cervical Radiculopathy
Interventions: Other: Gabapentin and/or Nortriptyline, Physical therapy; Procedure: Epidural Steroid Injections (ESI); Other: Combination treatment
Sponsors: Johns Hopkins University; Johns Hopkins University; Walter Reed Army Medical Center
Recruiting - verified September 2010 - Condition: Vulvodynia
Intervention: Drug: Gabapentin
Sponsors: University of Tennessee; University of Tennessee; University of Tennessee Health Science Center
Not yet recruiting - verified November 2011 - Condition: Parkinson's Disease
Interventions: Drug: Amantadine; Drug: Placebo
Sponsors: Rush University Medical Center; Rush University Medical Center; Michael J. Fox Foundation for Parkinson's Research
Recruiting - verified July 2011 - Conditions: Pain; Breast Cancer; Lung Cancer
Interventions: Drug: Gabapentin; Drug: Placebo
Sponsors: Stanford University; Stanford University
Recruiting - verified September 2011 - Condition: Depression
Intervention: Drug: Pramipexole
Sponsors: Stanford University; Stanford University
Recruiting - verified August 2010 - Condition: Opioid Dependence
Interventions: Drug: Memantine; Drug: Memantine; Drug: Placebo
Sponsors: University of Massachusetts, Worcester; University of Massachusetts, Worcester; National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2012 - Conditions: Schizophrenia; Schizophreniform Disorder
Interventions: Drug: Citalopram; Behavioral: Psychoeducation; Behavioral: Cognitive Behavioral Therapy (CBT); Radiation: Functional Magnetic Resonance Imaging (fMRI); Drug: Placebo; Behavioral: Psychoeducation; Behavioral: Cognitive Behavioral Therapy (CBT); Radiation: Functional Magnetic Resonance Imaging (fMRI)
Sponsors: National Institute of Mental Health (NIMH); National Institute of Mental Health (NIMH)
Recruiting - verified December 2011 - Condition: Epilepsy
Interventions: Drug: Namenda; Other: Sugar Pill; Drug: Memantine
Sponsors: American Academy of Neurology; American Academy of Neurology; Forest Laboratories
Recruiting - verified November 2011 - Condition: Hot Flashes
Intervention: Drug: Gabapentin
Sponsors: Abramson Cancer Center of the University of Pennsylvania; Abramson Cancer Center of the University of Pennsylvania
Recruiting - verified May 2012 - Condition: Tobacco Use Disorder
Interventions: Drug: Tolcapone; Drug: Placebo
Sponsors: University of Pennsylvania; University of Pennsylvania; National Institute on Drug Abuse (NIDA)
Recruiting - verified January 2012 - Conditions: Perceptual Disorders; Hemisensory Neglect; Hemispatial Neglect; Sensory Neglect; Somatosensory Discrimination Disorder
Interventions: Drug: bromocriptine; Behavioral: prism goggles
Sponsors: Kessler Foundation; Kessler Foundation; National Institutes of Health (NIH)
Recruiting - verified September 2010 - Conditions: Cannabis Dependence; Cannabis Withdrawal; Cognitive Deficits
Interventions: Drug: gabapentin 1200mg/day; Drug: Placebo
Sponsors: The Scripps Research Institute; The Scripps Research Institute
Recruiting - verified March 2012 - Condition: Back Pain
Interventions: Behavioral: cognitive behavioral therapy; Drug: desipramine hydrochloride; Behavioral: cognitive behavioral therapy; Drug: benztropine mesylate 0.125 mg daily; Drug: desipramine hydrochloride
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; University of California, San Diego
Recruiting - verified April 2012 - Condition: Obsessive-Compulsive Disorder
Intervention: Drug: Memantine
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute
Recruiting - verified April 2012 - Condition: Postoperative Pain
Interventions: Drug: Gabapentin; Drug: pregabalin
Sponsors: Loma Linda University; Loma Linda University
Recruiting - verified March 2012 - Condition: Major Depressive Disorder
Intervention: Drug: escitalopram and adjunctive aripiprazole and placebo
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified August 2011 - Conditions: Spatial Neglect; Hemispatial Neglect; Hemineglects; Unilateral Neglect; Unilateral Inattention; Sensory Neglect
Intervention:
Sponsors: Kessler Foundation; Kessler Foundation; National Institutes of Health (NIH); National Institute of Neurological Disorders and Stroke (NINDS); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified April 2012 - Condition: Alzheimer's Disease
Intervention: Drug: memantine
Sponsors: New York University School of Medicine; New York University School of Medicine
Recruiting - verified July 2011 - Condition: Pathological Gambling
Intervention: Drug: Tolcapone
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute
Recruiting - verified March 2012 - Conditions: Alzheimer's Disease; Agitation
Interventions: Drug: citalopram; Drug: placebo
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute on Aging (NIA); National Institute of Mental Health (NIMH)
Recruiting - verified May 2012 - Condition: Short Bowel Syndrome
Intervention: Drug: Citalopram
Sponsors: University of Nebraska; University of Nebraska
Recruiting - verified August 2011 - Condition: Kleptomania
Intervention: Drug: Memantine
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute
Recruiting - verified March 2012 - Condition: Major Depressive Disorder
Intervention: Drug: Creatine Monohydrate
Sponsors: University of Utah; University of Utah; AlzChem, LLC
Recruiting - verified April 2012 - Condition: Postpartum Depression
Intervention: Drug: Escitalopram
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Forest Laboratories
Recruiting - verified July 2011 - Conditions: Mood Disorder; Mental Disorder Diagnosed in Childhood; Attention Deficit and Disruptive Behavior Disorder; Attention Deficit Hyperactivity Disorder
Interventions: Drug: Citalopram; Drug: Methylphenidate
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified July 2011 - Conditions: Brain Injury; Aggression
Interventions: Drug: Amantadine Hydrochloride; Drug: Placebo
Sponsors: Carolinas Healthcare System; Carolinas Healthcare System; Indiana University; University of Washington; The Institute for Rehabilitation and Research; Spaulding Rehabilitation Hospital; Ohio State University; Mount Sinai School of Medicine
Recruiting - verified February 2012 - Condition: Brain Injury
Interventions: Drug: Apomorphine; Drug: Placebo
Sponsors: FDA Office of Orphan Products Development; NeuroHealing Pharmaceuticals Inc.; FDA Office of Orphan Products Development
Recruiting - verified July 2011 - Condition: Stroke
Interventions: Drug: Sinemet, ritalin, amphetamine, and placebo; Device: Transcranial magnetic stimulation (TMS); Other: Combined drug treatment and TMS
Sponsors: Emory University; Emory University; National Institutes of Health (NIH); National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified April 2012 - Condition: Depression
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified December 2011 - Condition: Major Depressive Disorder
Interventions: Drug: Escitalopram; Drug: Sertraline; Drug: Venlafaxine XR
Sponsors: BRC Operations Pty. Ltd.; BRC Operations Pty. Ltd.
Recruiting - verified March 2012 - Conditions: Postural Tachycardia Syndrome; Orthostatic Intolerance
Interventions: Drug: Carbidopa; Drug: Placebo
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified June 2011 - Conditions: Breast Cancer; Depression; Hot Flashes; Psychosocial Effects of Cancer and Its Treatment
Interventions: Drug: citalopram hydrobromide; Drug: escitalopram oxalate; Drug: gabapentin; Drug: sertraline hydrochloride; Drug: tamoxifen citrate; Drug: venlafaxine; Genetic: molecular genetic technique; Other: high performance liquid chromatography; Other: laboratory biomarker analysis; Other: pharmacological study; Procedure: adjuvant therapy
Sponsors: Mayo Clinic; Mayo Clinic; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Conditions: Diabetic Neuropathic Pain; Chronic Low Back Pain
Interventions: Drug: donepezil; Drug: duloxetine; Drug: donepezil 2.5 mg and duloxetine 30mg; Drug: placebo; Drug: gabapentin
Sponsors: Wake Forest University; Wake Forest University; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified February 2012 - Condition: Depression
Intervention: Drug: citalopram and escitalopram
Sponsors: Mayo Clinic; Mayo Clinic; National Institutes of Health (NIH)
Recruiting - verified May 2012 - Condition: Frontotemporal Lobar Degeneration
Intervention: Drug: Tolcapone
Sponsors: Columbia University; Columbia University; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified October 2011 - Conditions: Autonomic Nervous System Diseases; Orthostatic Hypotension
Interventions: Drug: droxidopa; Drug: placebo; Drug: alpha-methyldopa; Drug: carbidopa; Drug: metyrosine; Drug: levodopa; Drug: atomoxetine; Drug: metoclopramide
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified March 2012 - Conditions: Bipolar Disorder; Bipolar Depression
Interventions: Drug: citalopram + mood stabilizer; Procedure: FDG PET scans; Procedure: MRI structural scans; Procedure: Genotyping; Procedure: Blood Draw; Drug: placebo + mood stabilizer
Sponsors: Tufts Medical Center; Tufts Medical Center; National Institute of Mental Health (NIMH)
Recruiting - verified July 2011 - Condition: Depression
Interventions: Drug: Escitalopram; Drug: Desipramine
Sponsors: New York State Psychiatric Institute; New York State Psychiatric Institute; National Institute of Mental Health (NIMH)
Recruiting - verified April 2012 - Condition: Depression
Interventions: Drug: Escitalopram; Drug: Duloxetine; Behavioral: Cognitive behavioral therapy (CBT)
Sponsors: National Institute of Mental Health (NIMH); National Institute of Mental Health (NIMH); Emory University
Recruiting - verified December 2011 - Conditions: Tachycardia; Chronic Orthostatic Intolerance
Interventions: Drug: Acetazolamide; Drug: Atomoxetine; Other: Baseline (No Drug); Drug: Clonidine; Drug: Entacapone; Drug: Entacapone & Propranolol; Drug: Atomoxetine & Propranolol; Drug: Indomethacin; Drug: Mecamylamine; Drug: Isosorbide Dinitrate; Dietary Supplement: Melatonin; Drug: Midodrine; Drug: Modafinil; Drug: Octreotide; Radiation: Placebo; Drug: Propranolol; Drug: Modafinil & Propranolol; Drug: Sertraline; Procedure: IV Saline; Other: Drinking Water; Device: Breathing Device; Drug: memantine; Device: Abdominal binder
Sponsors: Vanderbilt University; Satish R. Raj; National Institutes of Health (NIH)
Recruiting - verified February 2012 - Condition: Functional Dyspepsia
Interventions: Drug: Amitriptyline; Drug: escitalopram; Drug: placebo
Sponsors: Mayo Clinic; Mayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified January 2012 - Condition: Alzheimer's Disease
Interventions: Drug: dl-alpha-tocopherol; Drug: Memantine; Drug: dl-alpha-tocopherol; Drug: Memantine; Drug: Placebo
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; Forest Laboratories; DSM Nutritional Products, Inc.
Recruiting - verified April 2012 - Conditions: Autonomic Failure; Orthostatic Hypotension
Interventions: Drug: Atomoxetine; Drug: Acarbose; Drug: Pyridostigmine Bromide; Drug: Yohimbine; Drug: Midodrine HCl; Drug: placebo; Drug: Modafinil; Drug: Octreotide; Other: water intake; Drug: Diphenhydramine Hydrochloride; Drug: Ranitidine HCL; Drug: Tranylcypromine; Drug: Ergotamine/ Caffeine; Drug: Celecoxib; Drug: Pseudoephedrine; Drug: Methylphenidate; Drug: Indomethacin; Drug: Ibuprofen; Drug: Oxymetazoline 0.05% nasal solution; Dietary Supplement: Bovril; Drug: Acetazolamide; Drug: Rivastigmine tartrate; Drug: Carbidopa/levodopa; Device: abdominal binder; Device: abdominal binder (sham)
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified May 2012 - Condition: Hypertension
Interventions: Drug: Clonidine; Drug: Nitroglycerin transdermal; Drug: Dipyridamole/ Aspirin (Aggrenox); Drug: Desmopressin (DDAVP); Drug: Sildenafil; Drug: Nifedipine; Drug: Hydralazine; Drug: Hydrochlorothiazide; Drug: Placebo; Drug: Bosentan; Drug: Diltiazem; Drug: Eplerenone; Drug: guanfacine; Dietary Supplement: L-arginine; Drug: captopril; Drug: carbidopa; Drug: losartan; Drug: metoprolol tartrate; Drug: nebivolol hydrochloride; Drug: prazosin hydrochloride; Drug: tamsulosin hydrochloride; Other: Head-up tilt.
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified May 2012 - Conditions: Anxiety Disorders; Somatoform Disorders
Interventions: Drug: Escitalopram; Drug: Placebo; Drug: Escitalopram extension
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; National Institute of Mental Health (NIMH); Rhode Island Hospital
Recruiting - verified May 2012 - Condition: Schizophrenia
Intervention: Drug: Tolcapone
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified February 2012
 |
Antiparkinson Agents Clinical Trials |
